DMHCA
DMHCA, a potent and selective LXR agonist, specifically activates the cholesterol efflux arm of the LXR pathway without stimulating triglyceride synthesis. DMHCA has anti-inflammatory effects and can be used for the research of cholesterol homeostasis diabetes[1].
Product Specifications
CAS Number
[79066-03-8]
UNSPSC
12352211
Target
LXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/dmhca.html
Purity
99.91
Solubility
DMSO : 7.69 mg/mL (ultrasonic)
Smiles
C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(N(C)C)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4(C(C[C@H](CC4)O)=CC3)C
Molecular Formula
C26H43NO2
Molecular Weight
401.63
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
HERG1 (Ether-a-go-go-related Gene Potassium Channel 1, Ether-a-go-go-related Protein 1, Eag-related Protein 1, ERG1, ERG-1, ERG, hERG1, hERG-1, HERG, H-ERG, Eag Homolog, Kv11.1, LQT2, Potassium Voltage-gated Channel Subfamily H Member 2, KCNH2, SQT1, Volt
HERG1 (Ether-a-go-go-related Gene Potassium Channel 1, Ether-a-go-go-related Protein 1, Eag-related Protein 1, ERG1, ERG-1, ERG, hERG1, hERG-1, HERG, H-ERG, Eag Homolog, Kv11.1, LQT2, Potassium Voltage-gated Channel Subfamily H Member 2, KCNH2, SQT1, Volt